Financial statements Lek - Pharm A. Opalińska
Balance sheet of Lek - Pharm A. Opalińska
Company age:
Age:
8 y. 10 m. 14 d.
Balance sheet data of LEK - PHARM A. OPALIŃSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 513 367,97 | 623 454,78 | 239 170,29 | 199 625,68 | 278 327,50 | 405 963,98 |
| A. Fixed assets | 97 071,94 | 97 815,88 | 63 222,16 | 46 758,52 | 36 799,19 | 102 504,00 |
| B. Current assets | 416 296,03 | 525 638,90 | 175 948,13 | 152 867,16 | 241 528,31 | 303 459,98 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 513 367,97 | 623 454,78 | 239 170,29 | 199 625,68 | 278 327,50 | 405 963,98 |
| A. Equity | 265 255,59 | 366 317,78 | 25 693,98 | -15 642,32 | 23 653,46 | 139 657,98 |
| B. Liabilities and provisions for liabilities | 248 112,38 | 257 137,00 | 213 476,31 | 215 268,00 | 254 674,04 | 266 306,00 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 246 626,42 | 257 137,00 | 212 676,31 | 214 468,00 | 254 358,74 | 265 445,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.